B. Eastwood

发表

Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.

D. Malatjalian, J. Ross, C. Williams, 1996, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Squamous Cell Carcinoma of the Bladder and the Challenges of Treatment for Rarer Histological Variants

B. Eastwood, Bchir, MA JeremyCrew, 2020 .

Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.

S. Halperin, B. Law, B. Eastwood, 1994, Archives of pediatrics & adolescent medicine.

Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine.

S. Halperin, E. Mills, B. Eastwood, 1997, Vaccine.

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age.

S. Halperin, D. Scheifele, B. Eastwood, 1999, The Pediatric infectious disease journal.

Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine.

J. Langley, S. Halperin, B. Eastwood, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Parental willingness to enter a child in a controlled vaccine trial.

J. Langley, S. Halperin, E. Mills, 1998, Clinical and investigative medicine. Medecine clinique et experimentale.

Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture.

S. Halperin, B. Eastwood, A. C. Nestruck, 1998, Vaccine.

Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.

S. Halperin, H. Davies, B. Eastwood, 1997, The Journal of pediatrics.

Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections.

J. Langley, B. Eastwood, S. Halperin, 1997, Pediatrics.

Comparison of parental and health care professional preferences for the acellular or whole cell pertussis vaccine.

B. Eastwood, S. Halperin, B. Eastwood, 1998, The Pediatric infectious disease journal.

Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.

K. Reisinger, S. Halperin, H. Keyserling, 1995, Scandinavian journal of infectious diseases.

Long-term results of combined interstitial gold seed implantation plus external beam irradiation in localised carcinoma of the prostate.

S. Lannon, B. Eastwood, S. Awad, 1993, British journal of urology.

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life.

S. Halperin, B. Eastwood, L. Barreto, 1996, Vaccine.

Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age.

S. Halperin, E. Mills, B. Eastwood, 1995, The Pediatric infectious disease journal.